Labcorp is taking a significant step toward modernizing medical diagnostics by expanding its partnership with PathAI to deploy the AISight Dx platform across its entire U.S. network. This move transitions traditional glass-slide microscopy into a digital-first environment, allowing pathologists to review, interpret, and manage high-resolution images of tissue samples on computer screens rather than under a lens.

The platform leverages advanced algorithms to assist in primary diagnosis, providing pathologists with automated image analysis and secure storage. By digitizing the workflow, Labcorp aims to reduce the time it takes for patients to receive results while ensuring greater consistency across different laboratory sites. The system essentially acts as a specialized assistant that can highlight areas of interest, helping doctors know exactly where to focus their attention within complex tissue structures.

This rollout follows a series of regulatory milestones, including FDA clearances that allow PathAI to update its platform with new scanners and file formats without repeated lengthy reviews. As Labcorp integrates these AI insights into routine care, the healthcare giant is also exploring broader applications, such as virtual tissue staining. This technique allows labs to process samples in multiple ways digitally, potentially revolutionizing how we identify and treat diseases at the cellular level.

Labcorp is taking a significant step toward modernizing medical diagnostics by expanding its partnership with PathAI to deploy the AISight Dx platform across its entire U.S. network. This move transitions traditional glass-slide microscopy into a digital-first environment, allowing pathologists to review, interpret, and manage high-resolution images of tissue samples on computer screens rather than under a lens.

The platform leverages advanced algorithms to assist in primary diagnosis, providing pathologists with automated image analysis and secure storage. By digitizing the workflow, Labcorp aims to reduce the time it takes for patients to receive results while ensuring greater consistency across different laboratory sites. The system essentially acts as a specialized assistant that can highlight areas of interest, helping doctors know exactly where to focus their attention within complex tissue structures.

This rollout follows a series of regulatory milestones, including FDA clearances that allow PathAI to update its platform with new scanners and file formats without repeated lengthy reviews. As Labcorp integrates these AI insights into routine care, the healthcare giant is also exploring broader applications, such as virtual tissue staining. This technique allows labs to process samples in multiple ways digitally, potentially revolutionizing how we identify and treat diseases at the cellular level.